← Back to Companies

Kestra Medical Technologies

Medical device company developing wearable cardiac monitoring and defibrillation technology to protect patients at risk of sudden cardiac arrest.

Location
Kirkland, Washington, USA
Founded
2014
Categories
medical-devices, cardiovascular, wearable, sudden-cardiac-arrest

Notes

Kestra Medical Technologies is developing wearable cardiac monitoring and defibrillation technology to protect patients at risk of sudden cardiac arrest (SCA). The company's ASSURE Wearable Cardioverter Defibrillator (WCD) provides continuous monitoring and automatic defibrillation for patients at risk of life-threatening arrhythmias.

Sudden cardiac arrest claims over 350,000 lives annually in the United States alone. Wearable defibrillators provide protection for patients who may not be candidates for implantable devices or who need temporary protection during a high-risk period.

Kestra is backed by Bain Capital Life Sciences and other medical device investors, and competes with ZOLL Medical's LifeVest in the wearable defibrillator market.

Team

Additional Research Findings

  • Founded in 2014, headquartered in Kirkland, Washington
  • Portfolio company of Bain Capital Life Sciences
  • ASSURE Wearable Cardioverter Defibrillator
  • Continuous cardiac monitoring + automatic defibrillation
  • FDA-cleared medical device
  • Protecting patients from sudden cardiac arrest
  • Competes with ZOLL Medical's LifeVest
  • Growing wearable medical device market
  • Seattle-area medical device company

Sources